United States
Premiumsupplier
Lorvotuzumab mertansine CAS NO.1008106-64-6
- Min.Order: 0
- Payment Terms:
- Product Details
Keywords
- IMGN901
- IMGN-901
Quick Details
- ProName: Lorvotuzumab mertansine
- CasNo: 1008106-64-6
- Application: For research use only.
- Purity: 95%
- LimitNum: 0
Superiority
We provide customized and high-quality Lorvotuzumab mertansine product for your project.
Details
Lorvotuzumab mertansine is an ADC consists of a CD56-targeting antibody conjugated with an antimitotic agent. Lorvotuzumab mertansine is designed for the treatment of CD56-expressing cancers.
